Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Net Cash Flow (2016 - 2026)

Collegium Pharmaceutical has reported Net Cash Flow over the past 10 years, most recently at $81.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 156.79% year-over-year to $81.2 million; the TTM value through Dec 2025 reached $155.5 million, up 208.48%, while the annual FY2025 figure was $155.5 million, 208.48% up from the prior year.
  • Net Cash Flow for Q4 2025 was $81.2 million at Collegium Pharmaceutical, up from $32.8 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $95.8 million in Q1 2023 and troughed at -$108.9 million in Q3 2024.
  • A 5-year average of $3.8 million and a median of $12.1 million in 2022 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 680.51% in 2022 and fell as far as 1019.16% in 2022.
  • Year by year, Net Cash Flow stood at -$6.8 million in 2021, then skyrocketed by 680.51% to $39.6 million in 2022, then plummeted by 149.5% to -$19.6 million in 2023, then skyrocketed by 261.37% to $31.6 million in 2024, then surged by 156.79% to $81.2 million in 2025.
  • Business Quant data shows Net Cash Flow for COLL at $81.2 million in Q4 2025, $32.8 million in Q3 2025, and $21.2 million in Q2 2025.